Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Laura H van der Meer-Kappelle"'
Autor:
A. J. L. M. Geraerds, Wendy van Herk, Martin Stocker, Salhab el Helou, Sourabh Dutta, Matteo S. Fontana, Frank A. B. A. Schuerman, Rita K. van den Tooren-de Groot, Jantien Wieringa, Jan Janota, Laura H. van der Meer-Kappelle, Rob Moonen, Sintha D. Sie, Esther de Vries, Albertine E. Donker, Urs Zimmerman, Luregn J. Schlapbach, Amerik C. de Mol, Angelique Hoffman-Haringsma, Madan Roy, Maren Tomaske, René F. Kornelisse, Juliette van Gijsel, Eline G. Visser, Annemarie M. C. van Rossum, Suzanne Polinder
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-11 (2021)
Abstract Backgrounds The large, international, randomized controlled NeoPInS trial showed that procalcitonin (PCT)-guided decision making was superior to standard care in reducing the duration of antibiotic therapy and hospitalization in neonates sus
Externí odkaz:
https://doaj.org/article/81f8bed465e94931874422ffb63889fc
Autor:
Fleur M Keij, René F Kornelisse, Nico G Hartwig, Jacqueline van der Sluijs-Bens, Ron H T van Beek, Arianne van Driel, Linda G M van Rooij, Ilka van Dalen-Vink, Gertjan J A Driessen, Sandra Kenter, Jeannette S von Lindern, Marianne Eijkemans, Gerda M Stam-Stigter, Hongchao Qi, Maartje M van den Berg, Martin G A Baartmans, Laura H van der Meer-Kappelle, Clemens B Meijssen, Obbe F Norbruis, Jojanneke Heidema, Maaike C van Rossem, Paul C P den Butter, Karel Allegaert, Irwin K M Reiss, Gerdien A Tramper-Stranders
Publikováno v:
The Lancet Child and Adolescent Health, 6(11), 799-809. Elsevier
Background: Switching from intravenous antibiotic therapy to oral antibiotic therapy among neonates is not yet practised in high-income settings due to uncertainties about exposure and safety. We aimed to assess the efficacy and safety of early intra
Autor:
Martin Stocker, Salhab el Helou, Luregn J Schlapbach, Juliette van Gijsel, Frans B Plötz, Jan Janota, René F Kornelisse, Dirk Lehnick, Niek B. Achten, Rob Moonen, Albertine E Donker, Urs Zimmerman, Wendy van Herk, Imant Daunhawer, Rita K van den Tooren-de Groot, Annemarie M. C. van Rossum, Angelique Hoffmann-Haringsma, Sven Wellmann, Madan Roy, Jantien W Wieringa, Laura H van der Meer-Kappelle, Frank A B A Schuerman, Sourabh Dutta, Maren Tomaske, Julia E. Vogt, Esther de Vries, Sintha D Sie, Amerik C. de Mol
Publikováno v:
Stocker, M, Daunhawer, I, van Herk, W, el Helou, S, Dutta, S, Schuerman, F A B A, van den Tooren-de Groot, R K, Wieringa, J W, Janota, J, van der Meer-Kappelle, L H, Moonen, R, Sie, S D, de Vries, E, Donker, A E, Zimmerman, U, Schlapbach, L J, de Mol, A C, Hoffmann-Haringsma, A, Roy, M, Tomaske, M, Kornelisse, R F, van Gijsel, J, Plötz, F B, Wellmann, S, Achten, N B, Lehnick, D, van Rossum, A M C & Vogt, J E 2022, ' Machine Learning Used to Compare the Diagnostic Accuracy of Risk Factors, Clinical Signs and Biomarkers and to Develop a New Prediction Model for Neonatal Early-onset Sepsis ', Pediatric Infectious Disease Journal, vol. 41, no. 3, pp. 248-254 . https://doi.org/10.1097/INF.0000000000003344
Pediatric Infectious Disease Journal, 41(3), 248-254. Lippincott Williams and Wilkins
The Pediatric infectious disease journal, 41(3), 248-254. Lippincott Williams & Wilkins
Pediatric Infectious Disease Journal, 41(3), 248-254. Lippincott Williams and Wilkins Ltd.
Pediatric infectious disease journal, 41(3), 248-254. Lippincott Williams and Wilkins
Pediatric Infectious Disease Journal, 41(3), 248-254. Lippincott Williams and Wilkins
The Pediatric infectious disease journal, 41(3), 248-254. Lippincott Williams & Wilkins
Pediatric Infectious Disease Journal, 41(3), 248-254. Lippincott Williams and Wilkins Ltd.
Pediatric infectious disease journal, 41(3), 248-254. Lippincott Williams and Wilkins
Background: Current strategies for risk stratification and prediction of neonatal early-onset sepsis (EOS) are inefficient and lack diagnostic performance. The aim of this study was to use machine learning to analyze the diagnostic accuracy of risk f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb09507fffc3911b56d3f583d5e66116
https://research.vumc.nl/en/publications/cabbad12-9f51-4d21-8b28-01a829d44d56
https://research.vumc.nl/en/publications/cabbad12-9f51-4d21-8b28-01a829d44d56
Autor:
Albertine E Donker, Suzanne Polinder, Urs Zimmerman, Matteo Fontana, Martin Stocker, Sintha D. Sie, Juliette van Gijsel, Rob Moonen, René F. Kornelisse, Salhab el Helou, Madan Roy, Rita K van den Tooren-de Groot, Luregn J. Schlapbach, Esther de Vries, Jan Janota, Sourabh Dutta, Wendy van Herk, Angelique Hoffman-Haringsma, Jantien W Wieringa, Maren Tomaske, Eline G. Visser, Laura H van der Meer-Kappelle, A. J. L. M. Geraerds, Amerik C. de Mol, Frank A B A Schuerman, Annemarie M. C. van Rossum
Publikováno v:
Critical Care, 25(1):367. BioMed Central Ltd.
Critical Care, 25:367. BioMed Central Ltd.
Critical Care, Vol 25, Iss 1, Pp 1-11 (2021)
Critical Care. Springer Science + Business Media
Geraerds, A J L M, van Herk, W, Stocker, M, el Helou, S, Dutta, S, Fontana, M S, Schuerman, F A B A, van den Tooren-de Groot, R K, Wieringa, JW, Janota, J, van der Meer-Kappelle, L H, Moonen, R, Sie, SD, de Vries, E, Donker, A E, Zimmerman, U, Schlapbach, L J, de Mol, AC, Hoffman-Haringsma, A, Masius, R, Tomaske, M, Kornelisse, R F, van Gijsel, J, Visser, E G, van Rossum, A M C & Polinder, S 2021, ' Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates Open Access ', Critical Care . https://doi.org/10.1186/s13054-021-03789-x
Critical Care
Critical Care, 25:367. BioMed Central Ltd.
Critical Care, Vol 25, Iss 1, Pp 1-11 (2021)
Critical Care. Springer Science + Business Media
Geraerds, A J L M, van Herk, W, Stocker, M, el Helou, S, Dutta, S, Fontana, M S, Schuerman, F A B A, van den Tooren-de Groot, R K, Wieringa, JW, Janota, J, van der Meer-Kappelle, L H, Moonen, R, Sie, SD, de Vries, E, Donker, A E, Zimmerman, U, Schlapbach, L J, de Mol, AC, Hoffman-Haringsma, A, Masius, R, Tomaske, M, Kornelisse, R F, van Gijsel, J, Visser, E G, van Rossum, A M C & Polinder, S 2021, ' Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates Open Access ', Critical Care . https://doi.org/10.1186/s13054-021-03789-x
Critical Care
Backgrounds The large, international, randomized controlled NeoPInS trial showed that procalcitonin (PCT)-guided decision making was superior to standard care in reducing the duration of antibiotic therapy and hospitalization in neonates suspected of
Autor:
Rita K van den Tooren-de Groot, Paul T. Heath, Juliette van Gijsel, Eline G. Visser, Dirk Lehnick, Salhab el Helou, Esther de Vries, Wendy van Herk, Frank A B A Schuerman, René F. Kornelisse, Maren Tomaske, Annemarie M. C. van Rossum, Madan Roy, Jantien W Wieringa, Frans B. Plötz, Jan Janota, Luregn J. Schlapbach, Sintha D. Sie, Urs Zimmerman, Laura H van der Meer-Kappelle, Niek B. Achten, Albertine E Donker, Angelique Hoffman-Haringsma, Martin Stocker, Rob Moonen, Sourabh Dutta, Amerik C. de Mol
Publikováno v:
Clinical infectious diseases, 73(2), e383-e390. Oxford University Press
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(2), e383-e390. Oxford University Press
Stocker, M, van Herk, W, el Helou, S, Dutta, S, Schuerman, F A B A, van den Tooren-de Groot, R K, Wieringa, JW, Janota, J, van der Meer-Kappelle, L H, Moonen, R, Sie, SD, de Vries, E, Donker, A E, Zimmerman, U, Schlapbach, L J, de Mol, AC, Hoffman-Haringsma, A, Roy, M, Tomaske, M, Kornelisse, R F, van Gijsel, J, Visser, E G, Plötz, F B, Achten, N B & van Rossum, A M C 2021, ' C-Reactive Protein, Procalcitonin, and White Blood Count to Rule Out Neonatal Early-onset Sepsis Within 36 Hours: A Secondary Analysis of the Neonatal Procalcitonin Intervention Study ', Clinical Infectious Diseases . https://doi.org/10.1093/cid/ciaa876
Clinical Infectious Diseases. Oxford University Press
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(2), e383-e390. Oxford University Press
Stocker, M, van Herk, W, el Helou, S, Dutta, S, Schuerman, F A B A, van den Tooren-de Groot, R K, Wieringa, JW, Janota, J, van der Meer-Kappelle, L H, Moonen, R, Sie, SD, de Vries, E, Donker, A E, Zimmerman, U, Schlapbach, L J, de Mol, AC, Hoffman-Haringsma, A, Roy, M, Tomaske, M, Kornelisse, R F, van Gijsel, J, Visser, E G, Plötz, F B, Achten, N B & van Rossum, A M C 2021, ' C-Reactive Protein, Procalcitonin, and White Blood Count to Rule Out Neonatal Early-onset Sepsis Within 36 Hours: A Secondary Analysis of the Neonatal Procalcitonin Intervention Study ', Clinical Infectious Diseases . https://doi.org/10.1093/cid/ciaa876
Clinical Infectious Diseases. Oxford University Press
BACKGROUND Neonatal early-onset sepsis (EOS) is one of the main causes of global neonatal mortality and morbidity, and initiation of early antibiotic treatment is key. However, antibiotics may be harmful. METHODS We performed a secondary analysis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5106586d5c207cc098ccb6c84e287bc
https://pure.amc.nl/en/publications/creactive-protein-procalcitonin-and-white-blood-count-to-rule-out-neonatal-earlyonset-sepsis-within-36-hours-a-secondary-analysis-of-the-neonatal-procalcitonin-intervention-study(3fa753a2-f6e0-4588-8d23-e40078a15b98).html
https://pure.amc.nl/en/publications/creactive-protein-procalcitonin-and-white-blood-count-to-rule-out-neonatal-earlyonset-sepsis-within-36-hours-a-secondary-analysis-of-the-neonatal-procalcitonin-intervention-study(3fa753a2-f6e0-4588-8d23-e40078a15b98).html
Autor:
B Manai, M Stocker, Fam van den Dungen, Mathias Nelle, Matteo Fontana, Faba Schuerman, L de Ligt, M Visnovska, S Alliston, SD Sie, Mark Alan Fontana, Angelique Hoffman-Haringsma, S Hill, MM van Weissenbruch, René F. Kornelisse, Albertine E Donker, D Glauser, Wendy van Herk, R Kornelisse, N Lanz, Laura H van der Meer-Kappelle, Groot A van Rossum, Sintha D. Sie, R Moonen, S Dutta, EG Visser, M Strik, W van Herk, Rob Moonen, LJ Schlapbach, Salhab el Helou, Urs Zimmerman, Martin Stocker, A Donker, M Batstra, Jantien W Wieringa, Luregn J. Schlapbach, Peter Andriessen, GJ van der Geijn, Wim C. J. Hop, J van der Velden, AC de Mol, U Zimmerman, LH van der Meer-Kappelle, A van Rossum, David Pogorzelski, Sten P. Willemsen, S Siiskonen, Jan Janota, A Haringsma, Ipe Gondriet, Juliette van Gijsel, S el Helou, Y.B. de Rijke, S Willemsen, Sourabh Dutta, Esther de Vries, S Hoekstein, E.G.E. de Vries, Mac Broeren, M Hofhuis, Amerik C. de Mol, J van Gijsel, Eline G. Visser, J Bolt-Wieringa, V Grey, Frank A B A Schuerman, K Hauff, Maren Tomaske, Marc-André Roy, S Donker, A Bakry, Madan Roy, HK van den Tooren-de, S Kittanakom, J Janota, Daniel Stok, J Asch van Wijk, K Kalaniti, M Tomaske, Annemarie M. C. van Rossum, Rita K van den Tooren-de Groot
Publikováno v:
Stocker, M, van Herk, W, el Helou, S, Dutta, S, Fontana, M S, Schuerman, F A B A, van den Tooren-de Groot, R K, Wieringa, J W, Janota, J, van der Meer-Kappelle, L H, Moonen, R, Sie, S D, de Vries, E, Donker, A E, Zimmerman, U, Schlapbach, L J, de Mol, A C, Hoffman-Haringsma, A, Roy, M, Tomaske, M, Kornelisse, R F, van Gijsel, J, Visser, E G, Willemsen, S P, van Rossum, A M C & NeoPInS Study Group 2017, ' Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis : a multicentre, randomised controlled trial (NeoPIns) ', The Lancet, vol. 390, no. 10097, pp. 871-881 . https://doi.org/10.1016/S0140-6736(17)31444-7
Lancet (UK), 390(10097), 871-881. Elsevier Ltd.
The Lancet, 390(10097), 871-881. Elsevier Limited
Lancet (UK), 390(10097), 871-881. Elsevier Ltd.
The Lancet, 390(10097), 871-881. Elsevier Limited
Background Up to 7% of term and late-preterm neonates in high-income countries receive antibiotics during the first 3 days of life because of suspected early-onset sepsis. The prevalence of culture-proven early-onset sepsis is 0·1% or less in high-i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2fcd49b436336d996370910b9ffacc0
https://research.vumc.nl/en/publications/c69a05d1-c20f-4c78-ae0e-2da2022b86ae
https://research.vumc.nl/en/publications/c69a05d1-c20f-4c78-ae0e-2da2022b86ae
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 157(15)
Both neonates of male twins born at 30 weeks and 3 days gestation presented with late-onset sepsis caused by an infection with group B streptococci (GBS), shortly after one another. Although the younger twin recovered with a standard regimen of 10 da